Pediatric Cancer News and reporting on pediatric cancer. Oct 31, 2022 Epigenetic Signatures in Eye Predict Rare Tumor Aggressiveness, Treatment Response Premium Oct 17, 2022 NCI Will Study Day One Biopharmaceuticals' Tovorafenib in Solid Tumors, Hematologic Cancers Oct 13, 2022 St. Jude, Broad Institute, Dana-Farber Partner to Advance Pediatric Cancer Research Oct 13, 2022 Consortium Studying Children, Families to Understand Pediatric Cancer Risk, Tumor Development Premium Oct 7, 2022 Swiss Biotech PreComb Therapeutics Wants to Automate Functional Precision Medicine Premium Aug 18, 2022 CHOP, NCI Launch Big Data Resource to Spur Precision Pediatric Cancer Drug Development Premium Aug 4, 2022 Massey Cancer Center Researchers Exploring SHP2 Inhibitor Potential in Pediatric Neuroblastoma Premium Jul 15, 2022 Pfizer's Xalkori Gets FDA Approval for ALK-Positive Inflammatory Myofibroblastic Tumors Jul 12, 2022 NCCN Publishes First Guidelines for Pediatric Brain Cancer, Recommends Broad NGS Profiling Jul 6, 2022 Structural Variant Study Points to Pediatric Glioma Drivers, Prognostic Features Jun 16, 2022 Day One Bio Raises $150M in Public Offering of Common Stock Jun 14, 2022 Day One Bio's Tovorafenib Market Prospects Look Promising Based on Pediatric Glioma Trial Data Premium Jun 14, 2022 Day One Seeks to Raise $125M in Common Stock Offering Jun 6, 2022 With ASCO Data, Novartis' Tafinlar-Mekinist Heads Toward FDA for BRAF-Mutant Pediatric Brain Cancer Premium May 20, 2022 MSK Starts Offering Pediatric Cancer Patients Whole-Genome, Transcriptome Sequencing Premium Apr 29, 2022 St. Jude Program Installing Nanopore Sequencing in Low-Income Countries to Diagnose Pediatric Blood Cancers Premium Apr 20, 2022 Chinese Regulators Clear JW Therapeutics' Carteyva IND for Pediatric ALL Apr 20, 2022 Proof-of-Principle Study Points to Possibility of Monitoring Pediatric ALL With Plasma Samples Apr 13, 2022 RACE for Children Act Spurs Pharma to Study Molecularly Informed Drugs in Pediatric Cancer Patients Premium Apr 12, 2022 New Epigenomic Biomarker Could Predict CAR T-Cell Therapy Resistance in Advanced Childhood Leukemia Premium Load More Breaking News Flare Therapeutics Raises $123M in Oversubscribed Series B Funding Round William Blair Initiates Coverage of MDxHealth With Outperform Rating White House Report Outlines Goals to Advance Genomic Research, Precision Therapy Development In Brief This Week: Fore Biotherapeutics, RayzeBio, Gilead Sciences, Atossa Therapeutics Bayer to Assess Nubeqa in High-Risk, Early-Stage Hormone-Sensitive Prostate Cancer BridgeBio Begins Phase I/II Study of SHP2 Inhibitor, Opdivo in KRAS-Mutant Solid Tumors
